Abstract
Glioblastomas are the most malignant subtypes of glioma and many efforts are currently made to improve their characterization though molecular, microvascular, immunogenic and metabolomic approaches. The variability within pre-clinical tumor models may mimic glioma heterogeneity and force the development of innovative analytical methodologies. In this study, we investigate the metabolic variability within three rat models of glioma: C6, RG2 and F98, using in vivo magnetic resonance spectroscopy (1H MRS) and ex vivo high resolution magic angle spinning (1H HRMAS MRS). We used a multivariate statistic approach with orthogonal projection to latent structure-discriminant analysis (OPLS-DA) that was compared with univariate statistic. OPLS-DA reveals a clear separation between C6, RG2 and F98 tumors and, with the help of shared and unique structure plot (SUS-Plot), promotes a comprehensive view of their metabolic differences. Both in vivo and ex vivo analyses are similar but ex vivo 1H HRMAS MRS provides more robust results. In conclusion, MRS-based OPLS-DA appears sensitive enough to correctly predict the classification of tumors and to investigate the relationship between the host brain metabolism and the grafted tumor.
Similar content being viewed by others
Abbreviations
- Ace:
-
Acetate
- Ala:
-
Alanine
- Asp:
-
Aspartate
- Bet:
-
Betaine
- Cho:
-
Choline
- GABA:
-
Gamma-amino-butyric acid
- Gln:
-
Glutamine
- Glu:
-
Glutamate
- Gly:
-
Glycine
- GPC:
-
Glycerophosphocholine
- Gsh:
-
Glutathione
- Hyp:
-
Hypotaurine
- Lac:
-
Lactate
- M-ins:
-
Myo-inositol
- NAA:
-
N-acetylaspartate
- PC:
-
Phosphocholine
- tCr:
-
Total creatine (phosphocreatine and creatine)
- PE:
-
Phosphoethanolamine
- S-Ins:
-
Scyllo-inositol
- Tau:
-
Taurine
- MM:
-
Macromolecules
- MRS:
-
Magnetic resonance spectroscopy
- HRMAS:
-
High resolution magic angle spinning
- jMRUI:
-
Java based version of the Magnetic Resonance User Interface
- OPLS-DA:
-
Orthogonal projection to latent structure-discriminant analysis
- PCA:
-
Principal component analysis
- SUS-plot:
-
Shared and unique structure plot
- GBM:
-
Glioblastomas
- PRESS:
-
Point RESolved spectroscopy
- CPMG:
-
Carr-Purcell-Meiboom-Gill CPMG
- CRLB:
-
Cramer Rao lower bounds
- FID:
-
Free induced decay
- NMR:
-
Nuclear magnetic resonance
References
Bansal, A., Shuyan, W., Hara, T., Harris, R. A., & DeGrado, T. R. (2008). Biodisposition and metabolism of [18F] fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats. European Journal of Nuclear Medicine and Molecular Imaging, 35(6), 1192–1203.
Barbier, E. L., Lamalle, L., & Décorps, M. (2001). Methodology of brain perfusion imaging. Journal of Magnetic Resonance Imaging, 13(4), 496–520.
Barth, R. F., & Kaur, B. (2009). Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. Journal of Neuro-oncology, 94(3), 299–312.
Bottomley, P. A. (1987). Spatial localization in NMR spectroscopy in vivo. Annals of the New York Academy of Sciences, 508(1), 333–348.
Bulik, M., Jancalek, R., Vanicek, J., Skoch, A., & Mechl, M. (2013). Potential of MR spectroscopy for assessment of glioma grading. Clinical Neurology and Neurosurgery, 115(2), 146–153.
Christen, T., Bouzat, P., Pannetier, N., Coquery, N., Moisan, A., Lemasson, B., et al. (2014). Tissue oxygen saturation mapping with magnetic resonance imaging. Journal of Cerebral Blood Flow and Metabolism, 34(9), 1550–1557.
Clemens, L. E., Jansson, E. K. H., Portal, E., Riess, O., & Nguyen, H. P. (2014). A behavioral comparison of the common laboratory rat strains Lister Hooded, Lewis, Fischer 344 and Wistar in an automated homecage system. Genes, Brain and Behavior, 13(3), 305–321.
Coquery, N., Francois, O., Lemasson, B., Debacker, C., Farion, R., Rémy, C., & Barbier, E. L. (2014). Microvascular MRI and unsupervised clustering yields histology-resembling images in two rat models of glioma. Journal of Cerebral Blood Flow and Metabolism, 34(8), 1354–1362.
Coquery, N., Pannetier, N., Farion, R., Herbette, A., Azurmendi, L., Clarencon, D., et al. (2012). Distribution and radiosensitizing effect of cholesterol-coupled dbait molecule in rat model of glioblastoma. PLoS One, 7(7), e40567.
Cuperlovic-Culf, M., Ferguson, D., Culf, A., Morin, P., & Touaibia, M. (2012). 1H NMR metabolomics analysis of glioblastoma subtypes correlation between metabolomics and gene expression characteristics. Journal of Biological Chemistry, 287(24), 20164–20175.
Dang, C. V. (2010). Rethinking the warburg effect with Myc micromanaging glutamine metabolism. Cancer Research, 70(3), 859–862.
de Graaf, R. A. (2007). Front matter. In vivo NMR spectroscopy (pp. i–xxi). John Wiley & Sons, Ltd.
Doblas, S., He, T., Saunders, D., Hoyle, J., Smith, N., Pye, Q., et al. (2012). In vivo characterization of several rodent glioma models by 1H MRS. NMR in Biomedicine, 25(4), 685–694.
Doblas, S., He, T., Saunders, D., Pearson, J., Hoyle, J., Smith, N., et al. (2010). Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography. Journal of Magnetic Resonance Imaging, 32(2), 267–275.
Erb, G., Elbayed, K., Piotto, M., Raya, J., Neuville, A., Mohr, M., et al. (2008). Toward improved grading of malignancy in oligodendrogliomas using metabolomics. Magnetic Resonance in Medicine, 59(5), 959–965.
Fauvelle, F., Carpentier, P., Dorandeu, F., Foquin, A., & Testylier, G. (2012). Prediction of neuroprotective treatment efficiency using a HRMAS NMR-Based statistical model of refractory status epilepticus on mouse: A metabolomic approach supported by histology. Journal of Proteome Research, 11(7), 3782–3795.
Glunde, K., Bhujwalla, Z. M., & Ronen, S. M. (2011). Choline metabolism in malignant transformation. Nature Reviews Cancer, 11(12), 835–848.
Golden, G. T., Smith, G. G., Ferraro, T. N., & Reyes, P. F. (1995). Rat strain and age differences in kainic acid induced seizures. Epilepsy Research, 20(2), 151–159.
Govindaraju, V., Young, K., & Maudsley, A. A. (2000). Proton NMR chemical shifts and coupling constants for brain metabolites. NMR in Biomedicine, 13(3), 129–153.
Griffin, J. L., & Shockcor, J. P. (2004). Metabolic profiles of cancer cells. Nature Reviews Cancer, 4(7), 551–561.
Grobben, B., Deyn, P. D., & Slegers, H. (2002). Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell and Tissue Research, 310(3), 257–270.
He, X., & Yablonskiy, D. A. (2007). Quantitative BOLD: Mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: Default state. Magnetic Resonance in Medicine, 57(1), 115–126.
Herz, R. C. G., Gaillard, P. J., de Wildt, D. J., & Versteeg, D. H. G. (1996). Differences in striatal extracellular amino acid concentrations between wistar and fischer 344 rats after middle cerebral artery occlusion. Brain Research, 715(1–2), 163–171.
Holmes, E., Tsang, T. M., & Tabrizi, S. J. (2006). The application of NMR-based metabonomics in neurological disorders. NeuroRx, 3(3), 358–372.
Hong, S.-T., Balla, D. Z., Choi, C., & Pohmann, R. (2011). Rat strain-dependent variations in brain metabolites detected by in vivo 1H NMR spectroscopy at 16.4T. NMR in Biomedicine, 24(10), 1401–1407.
Huszthy, P. C., Daphu, I., Niclou, S. P., Stieber, D., Nigro, J. M., Sakariassen, P. O., et al. (2012). In vivo models of primary brain tumors: pitfalls and perspectives. Neuro-Oncology, 14(8), 979–993.
Kanayama, S., Kuhara, S., & Satoh, K. (1996). In vivo rapid magnetic field measurement and shimming using single scan differential phase mapping. Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine, 36(4), 637–642.
Kauppinen, R. A., & Peet, A. C. (2011). Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring. Cancer Biology & Therapy, 12(8), 665–679.
Lemasson, B., Valable, S., Farion, R., Krainik, A., Rémy, C., & Barbier, E. L. (2013). In vivo imaging of vessel diameter, size, and density: A comparative study between MRI and histology. Magnetic Resonance in Medicine, 69(1), 18–26.
Opstad, K. S., Bell, B. A., Griffiths, J. R., & Howe, F. A. (2009). Taurine: A potential marker of apoptosis in gliomas. British Journal of Cancer, 100(5), 789–794.
Opstad, K. S., Wright, A. J., Bell, B. A., Griffiths, J. R., & Howe, F. A. (2010). Correlations between in vivo 1H MRS and ex vivo 1H HRMAS metabolite measurements in adult human gliomas. Journal of Magnetic Resonance Imaging, 31(2), 289–297.
Piotto, M., Moussallieh, F.-M., Dillmann, B., Imperiale, A., Neuville, A., Brigand, C., et al. (2009). Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy. Metabolomics, 5(3), 292–301.
Rabeson, H., Fauvelle, F., Testylier, G., Foquin, A., Carpentier, P., Dorandeu, F., et al. (2008). Quantitation with QUEST of brain HRMAS-NMR signals: Application to metabolic disorders in experimental epileptic seizures. Magnetic Resonance in Medicine, 59(6), 1266–1273.
Ratiney, H., Sdika, M., Coenradie, Y., Cavassila, S., van Ormondt, D., & Graveron-Demilly, D. (2005). Time-domain semi-parametric estimation based on a metabolite basis set. NMR in Biomedicine, 18(1), 1–13.
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England Journal of Medicine, 352(10), 987–996.
Tkáč, I., Starčuk, Z., Choi, I.-Y., & Gruetter, R. (1999). In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magnetic Resonance in Medicine, 41(4), 649–656.
Tofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., et al. (1999). Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusible tracer: Standardized quantities and symbols. Journal of Magnetic Resonance Imaging, 10(3), 223–232.
Troprès, I., Grimault, S., Vaeth, A., Grillon, E., Julien, C., Payen, J.-F., et al. (2001). Vessel size imaging. Magnetic Resonance in Medicine, 45(3), 397–408.
Valable, S., Lemasson, B., Farion, R., Beaumont, M., Segebarth, C., Remy, C., & Barbier, E. L. (2008). Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR in Biomedicine, 21(10), 1043–1056.
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., et al. (2010). An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell, 17(1), 98.
Weller, M., Stupp, R., Hegi, M., & Wick, W. (2012). Individualized targeted therapy for glioblastoma. The Cancer Journal, 18(1), 40–44.
Wieruszeski, J.-M., Montagne, G., Chessari, G., Rousselot-Pailley, P., & Lippens, G. (2001). Rotor synchronization of radiofrequency and gradient pulses in high-resolution magic angle spinning NMR. Journal of Magnetic Resonance, 152(1), 95–102.
Wiklund, S., Johansson, E., Sjöström, L., Mellerowicz, E. J., Edlund, U., Shockcor, J. P., et al. (2008). Visualization of GC/TOF-MS-Based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Analytical Chemistry, 80(1), 115–122.
Wilson, M., Davies, N. P., Grundy, R. G., & Peet, A. C. (2009). A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo1H HR-MAS for childhood brain tumours. NMR in Biomedicine, 22(2), 213–219.
Wold, S., Ruhe, A., Wold, H., & Dunn, W. J, I. I. I. (1984). The collinearity problem in linear regression. The partial least squares (PLS) approach to generalized inverses. SIAM Journal on Scientific and Statistical Computing, 5(3), 735–743.
Wright, A. J., Fellows, G. A., Griffiths, J. R., Wilson, M., Bell, B., & Howe, F. A. (2010). Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers. Molecular Cancer, 9(1), 66.
Yancey, P. H. (2005). Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses. Journal of Experimental Biology, 208(15), 2819–2830.
Ziegler, A., von Kienlin, M., Décorps, M., & Rémy, C. (2001). High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer Research, 61(14), 5595–5600.
Acknowledgments
We thank the animal care facility of GIN.
Funding
This study was funded by the French Service de Santé des Armées, the Fondation ARC (“Association pour la Recherche sur le Cancer”) and ANR (“Agence Nationale pour la Recherche”) Imoxy grant. IRMaGe was partly funded by the French program “Investissement d’Avenir” run by the “Agence Nationale pour la Recherche”; grant “Infrastructure d’avenir en Biologie Santé”—ANR-11-INBS-0006.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
The study design was approved by the local ethical committee for animal care and use (C2EA-04: “Comité d’éthique en expérimentation animale GIN”). Experiments were performed under permits (No. 38 12 63 and B 38 516 10 008 for experimental and animal care facilities) from the French Ministry of Agriculture.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary material 1 (TIFF 1409 kb)
Supplementary Table 1. Metabolite assignment
Supplementary material 2 (TIFF 2445 kb)
Supplementary Table 2. Details of statistical values presented in Table 1
Supplementary material 3 (TIFF 996 kb)
Supplementary Table 3. OPLS-DA models built with quantified 1H MRS data (in vivo) or 1H HRMAS MRS data (ex vivo) as x variables and tumor types as classes (C6, F98 and RG2). Cumulative values of R2X, R2Y and Q2 are given
Rights and permissions
About this article
Cite this article
Coquery, N., Stupar, V., Farion, R. et al. The three glioma rat models C6, F98 and RG2 exhibit different metabolic profiles: in vivo 1H MRS and ex vivo 1H HRMAS combined with multivariate statistics. Metabolomics 11, 1834–1847 (2015). https://doi.org/10.1007/s11306-015-0835-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-015-0835-2